CareDx, Inc. (CDNA)
77.88
-1.93
(-2.42%)
USD |
NASDAQ |
Nov 13, 16:00
77.00
-0.88
(-1.13%)
After-Hours: 19:59
CareDx Price to Book Value : 8.740 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 8.740 |
| November 12, 2026 | 8.957 |
| November 11, 2026 | 9.109 |
| November 10, 2026 | 9.064 |
| November 09, 2026 | 9.474 |
| November 06, 2026 | 8.816 |
| November 05, 2026 | 8.566 |
| November 04, 2026 | 9.636 |
| November 03, 2026 | 9.929 |
| November 02, 2026 | 9.638 |
| October 30, 2026 | 9.810 |
| October 29, 2026 | 8.026 |
| October 28, 2026 | 8.095 |
| October 27, 2026 | 7.915 |
| October 26, 2026 | 7.755 |
| October 23, 2026 | 7.767 |
| October 22, 2026 | 7.762 |
| October 21, 2026 | 7.939 |
| October 20, 2026 | 7.766 |
| October 19, 2026 | 7.528 |
| October 16, 2026 | 7.182 |
| October 15, 2026 | 7.483 |
| October 14, 2026 | 7.260 |
| October 13, 2026 | 7.343 |
| October 12, 2026 | 7.084 |
| Date | Value |
|---|---|
| October 09, 2026 | 7.145 |
| October 08, 2026 | 6.981 |
| October 07, 2026 | 7.075 |
| October 06, 2026 | 7.159 |
| October 05, 2026 | 7.839 |
| October 02, 2026 | 7.536 |
| October 01, 2026 | 7.433 |
| September 30, 2026 | 7.295 |
| September 29, 2026 | 7.744 |
| September 28, 2026 | 7.814 |
| September 25, 2026 | 7.703 |
| September 24, 2026 | 7.424 |
| September 23, 2026 | 6.570 |
| September 22, 2026 | 6.833 |
| September 21, 2026 | 6.572 |
| September 18, 2026 | 6.512 |
| September 17, 2026 | 6.566 |
| September 16, 2026 | 6.478 |
| September 15, 2026 | 6.368 |
| September 14, 2026 | 6.335 |
| September 11, 2026 | 6.080 |
| September 10, 2026 | 6.051 |
| September 09, 2026 | 6.052 |
| September 08, 2026 | 6.086 |
| September 04, 2026 | 6.155 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Natera, Inc. | 24.64 |
| Myriad Genetics, Inc. | 2.014 |
| BioRestorative Therapies, Inc. | 0.6274 |
| Exagen, Inc. | 7.622 |
| Sera Prognostics, Inc. | 1.523 |
Price to Book Value Related Metrics
| PE Ratio | 32.53 |
| PS Ratio | 8.324 |
| PEG Ratio | 0.3227 |
| Price to Free Cash Flow | 69.29 |
| Price | 77.88 |
| Earnings Yield | 3.07% |
| Market Cap | 4.086B |
| PEGY Ratio | 0.3227 |
| Operating PE Ratio | 966.74 |
| Normalized PE Ratio | 32.39 |